comprehensive -WSS

comprehensive

author：leisure time 2025-09-01 15:16:03 - browse：438

The back of three medicine containers, a bottle in between two boxes, all showing labels — coverage from STAT — Adobe

After a drug enters the market, it’s up to Food and Drug Administration regulators to ensure its continued safety and efficacy. A recent New York Times story suggests that, in the case of the popular asthma drug Singulair, the FDA fell short — both because the agency delayed action for years on reports from patient advocates and independent groups that the drug could cause suicidal thoughts, and because when it did add a warning label about its potential side effects in 2020, clinicians and patients still weren’t always aware of the risks.

Experts say that the Singulair incident highlights a flawed system, both in the U.S. and globally, for monitoring adverse reactions after a drug is on the market — one that will require extensive changes to address.

“The question is, how safe do you want to be?” said Ameet Sarpatwari, the assistant director of the Program on Regulation, Therapeutics, and Law at Brigham and Women’s Hospital. Ideally, he said, the FDA should be able to both stay on top of safety concerns and avoid unnecessarily restricting access to drugs. “Are we at the right balance? I think there are definitely situations for many drugs where you can say, no, we’re not really at the right balance, and the FDA should be taking a more aggressive stance in promoting patient safety.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Trump team launching legal defense fund to help pay legal bills

Wikipedia

WSS

Young Chinese opt out of the rat race and pressures at home to pursue global nomad lifestyle

HCA says smaller share of spending going to labor

Problems with a popular proposal to regulate AI in health care

Many immigrants are left out of maternal health programs

What’s missing from the debate over nursing home staff minimums

Johnson & Johnson sued for allegedly overpaying for workers' drugs

leisure time

comprehensive

leisure time

ChatGPT in medicine: STAT answers readers' burning questions

AstraZeneca stays mum on Medicare drug pricing negotiations

ChatGPT in medicine: STAT answers readers' burning questions

Texas Medical Board asked to define abortion emergency exception

Activists slam private health insurers over coverage restrictions

Trump PAC spent more than $40M on legal bills this year as his charges mount: Sources

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Sudan conflict brings new atrocities to Darfur as militias kill, rape, burn homes in rampages

Jerome Adams on the need for new antivirals for Covid

Judge orders hearing on Trump's motion to disqualify Fulton County DA

explore

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

Updated Covid vaccine has 54% effectiveness, new study suggests

Biden has enormous polling lead in Democratic primary, despite challenge from RFK Jr.

5 wounded, 2 critically, in Michigan shopping center shooting

Gene therapy for Afghan refugees’ infant will be fully covered

Gene therapy for Afghan refugees’ infant will be fully covered

Wikipedia

focus

focus

hotspot